Previous studies have reported that the serum concentration of DNASE1L3 protein is decreased in dermatomyositis, SLE, and rheumatoid arthritis, suggesting that DNASE1L3 may be involved in the development of autoimmune diseases [13]. Here, DNASE1L3 is linked to systemic lupus erythematosus.